ConductScience.org, home

Paper36969852

The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review.

Baghban N and 2 others. Front Pharmacol, 2023. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review. Papers, record 36969852. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969852

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review.
PubMed
Journal
Front Pharmacol
PubMed
Year
2023
PubMed
Publication types
Systematic Review, Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
1.29
iCite
Revised in PubMed
2024-09-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baghban NNeda
2Ullah MMujib
3Nabipour IIraj

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References94

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134680550Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer.Biomedicines2021https://conductscience.org/library/papers/34680550PubMed
233627627Exosomes in ovarian cancer ascites promote epithelial-mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p.Cell Death Dis2021https://conductscience.org/library/papers/33627627PubMed
333910598Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer.J Ovarian Res2021https://conductscience.org/library/papers/33910598PubMed
435003018Algal Cells-Derived Extracellular Vesicles: A Review With Special Emphasis on Their Antimicrobial Effects.Front Microbiol2021https://conductscience.org/library/papers/35003018PubMed
532326768microRNAs as biomarkers of ovarian cancer.Expert Rev Anticancer Ther2020https://conductscience.org/library/papers/32326768PubMed
626181817Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression.J Acquir Immune Defic Syndr2015https://conductscience.org/library/papers/26181817PubMed
730669512Extracellular Vesicle-Mediated Cell⁻Cell Communication in the Nervous System: Focus on Neurological Diseases.Int J Mol Sci2019https://conductscience.org/library/papers/30669512PubMed
834298602
Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence.
Cancers (Basel)2021https://conductscience.org/library/papers/34298602PubMed
930585260Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer.Int J Biol Sci2018https://conductscience.org/library/papers/30585260PubMed
1030864689Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.Int J Oncol2019https://conductscience.org/library/papers/30864689PubMed
1135871126IL-6 secretion of CD4+ T cells stimulated by LC3-positive extracellular vesicles in human epithelial ovarian cancer.Clin Transl Oncol2022https://conductscience.org/library/papers/35871126PubMed
1225579119The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells.Gynecol Oncol2015https://conductscience.org/library/papers/25579119PubMed
1319622511Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.Ann Intern Med2009https://conductscience.org/library/papers/19622511PubMed
1431839712miR-139 Controls Viability Of Ovarian Cancer Cells Through Apoptosis Induction And Exosome Shedding Inhibition By Targeting ATP7A.Onco Targets Ther2019https://conductscience.org/library/papers/31839712PubMed
1535025082Anti-lung Cancer Marine Compounds: A Review.Ther Innov Regul Sci2022https://conductscience.org/library/papers/35025082PubMed
1624102732Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.J Obstet Gynaecol Res2014https://conductscience.org/library/papers/24102732PubMed
1735414084The implications of exosomes in pregnancy: emerging as new diagnostic markers and therapeutics targets.Cell Commun Signal2022https://conductscience.org/library/papers/35414084PubMed
1830770776Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.J Exp Clin Cancer Res2019https://conductscience.org/library/papers/30770776PubMed
1930959137Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients.J Biotechnol2019https://conductscience.org/library/papers/30959137PubMed
2028216373TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA.Cancer Lett2017https://conductscience.org/library/papers/28216373PubMed

See all 94 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
40786044Critical dysregulated signaling pathways in drug resistance: highlighting the repositioning of mebendazole for cancer therapy.Front Pharmacol2025https://conductscience.org/library/papers/40786044PubMed
40207548Past, present, and future of exosomes research in cancer: A bibliometric and visualization analysis.Hum Vaccin Immunother2025https://conductscience.org/library/papers/40207548PubMed
39950738Exosomes in the Chemoresistance of Glioma: Key Point in Chemoresistance.J Cell Mol Med2025https://conductscience.org/library/papers/39950738PubMed
39048891Knowledge mapping of exosomes in prostate cancer from 2003 to 2022: a bibliometric analysis.Discov Oncol2024https://conductscience.org/library/papers/39048891PubMed
38473244Advances in 3D Culture Models to Study Exosomes in Triple-Negative Breast Cancer.Cancers (Basel)2024https://conductscience.org/library/papers/38473244PubMed
38391160Research prospects for kidney xenotransplantation: a bibliometric analysis.Ren Fail2024https://conductscience.org/library/papers/38391160PubMed
38111527Application of medical imaging in ovarian cancer: a bibliometric analysis from 2000 to 2022.Front Oncol2023https://conductscience.org/library/papers/38111527PubMed
37475778Role of CD9 Sensing, AI, and Exosomes in Cellular Communication of Cancer.Int J Stem Cell Res Ther2023https://conductscience.org/library/papers/37475778PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATP7A538PubTator's text mininghttps://conductscience.org/library/genes/538NCBI Gene
CAV1857PubTator's text mininghttps://conductscience.org/library/genes/857NCBI Gene
CD24100133941PubTator's text mininghttps://conductscience.org/library/genes/100133941NCBI Gene
MIR1307100302174PubTator's text mininghttps://conductscience.org/library/genes/100302174NCBI Gene
MIR139406931PubTator's text mininghttps://conductscience.org/library/genes/406931NCBI Gene
MIR181A1406995PubTator's text mininghttps://conductscience.org/library/genes/406995NCBI Gene
MIR200A406983PubTator's text mininghttps://conductscience.org/library/genes/406983NCBI Gene
MIR200B406984PubTator's text mininghttps://conductscience.org/library/genes/406984NCBI Gene
MIR200C406985PubTator's text mininghttps://conductscience.org/library/genes/406985NCBI Gene
MIR223407008PubTator's text mininghttps://conductscience.org/library/genes/407008NCBI Gene
MIR373442918PubTator's text mininghttps://conductscience.org/library/genes/442918NCBI Gene
MIR375494324PubTator's text mininghttps://conductscience.org/library/genes/494324NCBI Gene
MIR484619553PubTator's text mininghttps://conductscience.org/library/genes/619553NCBI Gene
MIR6126102465134PubTator's text mininghttps://conductscience.org/library/genes/102465134NCBI Gene
MUC1694025PubTator's text mininghttps://conductscience.org/library/genes/94025NCBI Gene
PGP283871PubTator's text mininghttps://conductscience.org/library/genes/283871NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36969852

GET https://conductscience.org/api/papers/v1/36969852/references?page=2